Market revenue in 2023 | USD 631.9 million |
Market revenue in 2030 | USD 982.8 million |
Growth rate | 6.5% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 72.12% in 2023. Horizon Databook has segmented the Brazil high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil has been experiencing positive economic growth due to financial and political stability in the region. Healthcare expenditure in Brazil is around USD 190 billion and is among the highest in the world. Biopharmaceutical industry is doing better than other industries in the country owing to increasing government investments to improve healthcare in the region.
According to The Gerontological Society of America, in 2018, Brazil was the largest country in Latin America and its population, which is over 200 million, is aging rapidly. According to WHO (2015) population aged over 60 has increased from 10% to 20% in less than 20 years in Brazil.
Brazil reports over 559,371 new cancer cases annually with breast cancer being the most prevalent. Rising prevalence of chronic diseases, such as cancer, and increasing awareness about disease management are boosting the demand for drugs in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil high potency active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Brazil high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account